Sangamo Therapeutics, Inc (SGMO): 8-K filed Jul 20, 2026

Form type

8-K

Filing date

Jul 20, 2026

Accession number

0001193125-26-309012

Filer

Sangamo Therapeutics, Inc (CIK 1001233)